Nafamostat (International)
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0081525-10-2
Chemical Formula
C19-H17-N5-O2
Molecular Weight
347
Therapeutic Category
Protease inhibitor
Chemical Name
Benzoic acid, 4-[(aminoiminometyl)amino]-, 6-(aminoiminometyl)-2-naphtalenyl ester
Foreign Names
- Nafamostatum (Latin)
- Nafamostat (German)
- Nafamostat (French)
- Nafamostat (Spanish)
Generic Names
- Nafamostat Mesilate (OS: JAN)
- Nafamostat Mesylate (OS: USAN)
- FUT 175 (IS)
- Nafamostat Mesilate (PH: JP XVII)
Brand Names
- Buipel
Takeda Teva Pharma, Japan - Coahibitor
AY Pharma, Japan - Famoset
Towa Yakuhin, Japan - Futhan
Torii Yakuhin, Japan - Nafamostat
Kobayashi Pharmaceutical, Japan; Sawai Seiyaku, Japan - Nafamostat Mesilate
Fuji Seiyaku, Japan; Kyoshi Mirai, Japan; Nichi-Iko Pharmaceutical, Japan; Tobishi Pharmaceutical, Japan - Nafatat
Nichi-Iko Pharmaceutical, Japan - Naotamin
Asahi Kasei Pharma, Japan - Opsun
Sanwa Kagaku, Japan - Ronastat
Koa Isei, Japan
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
